301080.SZ
301080.SZ
CNE100004S13
ACROBIOSYSTEMS
Loading chart...

Company Profile

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions. It provides kits, scientific services, and other related products under the Resilient Supply, CytoPak, SAFENSURE, FLAG, Star Staining, Aneuro, ComboX, and GENPower brands. The company also offers cell therapies, gene therapies, therapeutic antibodies, antibody-drug conjugates, core reagents for infectious disease research, and solutions for metabolic and autoimmune disease drug development. In addition, it provides custom reagent, assay development, and analytical services. Further, the company is involved in general business, sales and technical services of biological products, manufacture and sells medical devices, research and development of biological reagent products, business information consulting and conference, and company testing service businesses. The company's products are used in drug screening and optimization for diseases such as cancer, autoimmune diseases, cardiovascular diseases, and infectious diseases; diagnostic reagent development and optimization; preclinical and clinical trials; and drug manufacturing processes and process control. Acrobiosystems Co.,Ltd. was founded in 2010 and is based in Beijing, China.

Related stocks

301047.SZ
301047.SZ • China
SINO BIOLOGICAL
147.12 CNY
2.68B USD 1Y +99.2%
ZLAB
ZLAB • China
Zai Lab Limited
24.99 USD
2.81B USD 1Y -26.4%
9688.HK
9688.HK • China
ZAI LAB
19.25 HKD
2.75B USD 1Y -26.5%
688520.SS
688520.SS • China
SINOCELLTECH GROUP LTD
36.22 CNY
2.55B USD 1Y -35.8%
2696.HK
2696.HK • China
HENLIUS
50.75 HKD
3.53B USD 1Y -33%
9606.HK
9606.HK • China
DUALITYBIO-B
182.7 HKD
2.13B USD 1Y -42.1%
688105.SS
688105.SS • China
NANJING VAZYME BIOTECH CO LTD
26.6 CNY
2.06B USD 1Y +49.7%
1877.HK
1877.HK • China
JUNSHI BIO
17.65 HKD
2.31B USD 1Y -40.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
57.2% p.a.
Max Drawdown (5Y)
-80.8%
Sharpe Ratio (5Y)
0.11
Beta Factor
0.64
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 High valuation risk: Avg P/E of 114.2 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (57.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -80.8% in the extended horizon.
ende